Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yu Zhang, Jie Luo, Rongquan He, Wenting Huang, Zuyun Li, Ping Li, Yiwu Dang, Gang Chen & Shikang Li. (2016) Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases. OncoTargets and Therapy 9, pages 4959-4968.
Read now
Read now
Minhua Rong, Rongquan He, Yiwu Dang & Gang Chen. (2014) Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues. Upsala Journal of Medical Sciences 119:1, pages 19-24.
Read now
Read now
Articles from other publishers (12)
Hui-fang Zhu, Yan-ping Liu, Ding-li Liu, Yi-dan Ma, Zhi-yan Hu, Xiao-yan Wang, Chuan-sha Gu, Yan Zhong, Ting Long, He-ping Kan & Zu-guo Li. (2019) Role of TGFβ3-Smads-Sp1 axis in DcR3-mediated immune escape of hepatocellular carcinoma. Oncogenesis 8:8.
Crossref
Crossref
Hua Ge, Chaojie Liang, Shulin Ren, Chaosen Yue & Jixiang Wu. (2018) Prognostic value of DcR3 in solid tumors: A meta-analysis. Clinica Chimica Acta 481, pages 126-131.
Crossref
Crossref
Xiaoli Lou, Yanqiang Hou, Hui Cao, Jingjing Zhao & Fengting Zhu. (2018) Clinical significance of decoy receptor 3 upregulation in patients with hepatitis B and liver fibrosis. Oncology Letters.
Crossref
Crossref
Yan-Ping Liu, Hui-Fang Zhu, Ding-li Liu, Zhi-Yan Hu, Sheng-Nan Li, He-Ping Kan, Xiao-Yan Wang & Zu-Guo Li. (2016) DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC. Oncotarget 7:47, pages 77306-77318.
Crossref
Crossref
Giorgos Bamias, Michalis Gizis, Ioanna Delladetsima, Eyfrosyni Laoudi, Spyros I. Siakavellas, Ioannis Koutsounas, Garyfallia Kaltsa, John Vlachogiannakos, Irene Vafiadis-Zouboulis, George L. Daikos, George V. Papatheodoridis & Spiros D. Ladas. (2016) Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease. Canadian Journal of Gastroenterology and Hepatology 2016, pages 1-8.
Crossref
Crossref
Linjiang Pan, Suning Huang, Rongquan He, Minhua Rong, Yiwu Dang & Gang Chen. (2014) Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues. European Journal of Medical Research 19:1.
Crossref
Crossref
Yi-Qiang Jiang, Teng-Fei Zhong, Yi-Wu Dang, Ling-Song Zou, Liu Yang, Xia Yang & Gang Chen. (2014) Overexpression and Clinicopathological Contribution of DcR3 in Bladder Urothelial Carcinoma Tissues. Asian Pacific Journal of Cancer Prevention 15:21, pages 9137-9142.
Crossref
Crossref
WENYAN LI, FENG YANG, YONGXIAN GUI & JUNJIE BIAN. (2014) DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysis. Oncology Letters 8:4, pages 1725-1730.
Crossref
Crossref
Yi-Wu Dang, Jing Zeng, Rong-Quan He, Min-Hua Rong, Dian-Zhong Luo & Gang Chen. (2014) Effects of miR-152 on Cell Growth Inhibition, Motility Suppression and Apoptosis Induction in Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention 15:12, pages 4969-4976.
Crossref
Crossref
Suning Huang, Gang Chen, Yiwu Dang & Long-Hua Chen. (2014) Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma. The Scientific World Journal 2014, pages 1-7.
Crossref
Crossref
Suning Huang, Rongquan He, Minhua Rong, Yiwu Dang & Gang Chen. (2014) Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells. BioMed Research International 2014, pages 1-15.
Crossref
Crossref
Yiwu Dang, Dianzhong Luo, Minhua Rong & Gang Chen. (2013) Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET. PLoS ONE 8:4, pages e61054.
Crossref
Crossref